CoreCap Advisors’s Collegium Pharmaceutical COLL Stock Holding History

CoreCap Advisors’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,843	Closed	-$85.3K	–	2966
2025 Q4	$85.3K	Sell	1,843 -597	-24%	-$25K	﹤0.01%	1091
2025 Q3	$85.4K	Sell	2,440 -390	-14%	-$13.6K	﹤0.01%	1098
2025 Q2	$83.7K	Sell	2,830 -947	-25%	-$27K	﹤0.01%	1048
2025 Q1	$113K	Buy	+3,777	New	+$115K	0.01%	861

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

CoreCap Advisors's COLL Position: Q1 2026 in Review

CoreCap Advisors sold out of Collegium Pharmaceutical (COLL) in Q1 2026, closing a stake of 1,843 shares — an estimated $85.3K sold.

CoreCap Advisors first reported a position in COLL in Q1 2025 and held it in 4 quarters. The position peaked at $113K in Q1 2025. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

CoreCap Advisors reported no remaining Collegium Pharmaceutical position as of Q1 2026 after selling out during the quarter.
CoreCap Advisors sold 1,843 Collegium Pharmaceutical shares in Q1 2026, an estimated $85.3K.
CoreCap Advisors first reported a position in Collegium Pharmaceutical in Q1 2025 and held it in 4 quarters.
CoreCap Advisors's Collegium Pharmaceutical position peaked at $113K in Q1 2025.
266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on CoreCap Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.